Q-Cells SE: Application for the revocation of admission to the regulated market (General Standard) pursuant to section 39 (2) Stock Exchange Act in conjunction with section 46 (1) Stock Exchange Order (Börsenordnung) of the Frankfurt Stock Exchange

Q-Cells SE  / Key word(s): Delisting

30.08.2012 13:34

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bitterfeld-Wolfen (Germany), 30 August 2012. Today, Henning Schorisch,
lawyer and insolvency administrator for the assets of Q-Cells SE (ISIN
DE0005558662), applied with the management of the Frankfurt Stock Exchange
for the revocation of Q-Cells SE's admission to the regulated market
(General Standard) regarding its shares pursuant to section 39 (2) Stock
Exchange Act (Börsengesetz) in conjunction with section 46 (1) Stock
Exchange Order (Börsenordnung).

The shares of Q-Cells SE are currently listed on the Frankfurt Stock
Exchange in the regulated market sub-section with additional obligations
arising from admission (Prime Standard). The revocation of this admission
has already been applied for and approved by the management of the
Frankfurt Stock Exchange. Admission to the regulated market sub-section
with additional obligations arising from admission (Prime Standard) of the
Frankfurt Stock Exchange will terminate at midnight on 18 October 2012. As
a direct result, the Q-Cells SE shares will be admitted for trading on the
regulated market (General Standard) of Frankfurt Stock Exchange (a legally
required step) on 19 October 2012.

Today's application for the revocation of admission to the regulated market
(General Standard) aims to terminate this (last remaining) admission of the
shares to a regulated market so that the Q-Cells SE shares will be fully
delisted as soon as today's application becomes effective.

CONTACT

Q-Cells SE i.I.
OT Thalheim, Sonnenallee 17-21
06766 Bitterfeld-Wolfen, Germany
FAX +49 (0)3494 6699.10000
WEB www.q-cells.de

Q.CELLS Investor Relations
Stefan Lissner
TEL +49 (0)3494 6699.10101
EMAIL investor@q-cells.com

Q.CELLS Corporate Communications
Ina von Spies, Alberta Rohardt
TEL +49 (0)3494 6699.10121
EMAIL presse@q-cells.com

Lawyer Henning Schorisch as insolvency administrator of Q-Cells SE
Executive Board: Dr Nedim Cen (CEO, CFO), Dr Andreas v. Zitzewitz (COO,
CSO)
Chairman of the Supervisory Board: Prof Dr h c Karlheinz Hornung


30.08.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Q-Cells SE
              Sonnenallee 17-21, OT Thalheim
              06766 Bitterfeld-Wolfen
              Germany
Phone:        +49 (0)3494 - 6699-0
Fax:          +49 (0)3494 - 6699-199
E-mail:       q-cells@q-cells.com
Internet:     www.q-cells.com
ISIN:         DE0005558662, Wandelanleihe 2012: DE000A0LMY64, Wandelanleihe
              2014: DE000A1AGZ06, Wandelanleihe 2015: DE000A1E8HF6
WKN:          555866
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------